scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00105-016-3908-X |
P698 | PubMed publication ID | 28005146 |
P50 | author | Christian Möbs | Q45987149 |
P2093 | author name string | W Pfützner | |
P2860 | cites work | Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption | Q81553544 |
Diagnosing nonimmediate reactions to cephalosporins | Q83416742 | ||
Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs | Q84487709 | ||
Determining the negative predictive value of provocation tests with beta-lactams | Q84792062 | ||
Skin testing and patch testing in non-IgE-mediated drug allergy | Q87698771 | ||
Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review | Q28271185 | ||
Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response | Q28483831 | ||
Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. | Q34751819 | ||
Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance. | Q35519510 | ||
Diagnosis of immediate allergic reactions to beta‐lactam antibiotics | Q35544062 | ||
Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergolo | Q35777131 | ||
The lymphocyte transformation test in the diagnosis of drug hypersensitivity | Q35824801 | ||
Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. | Q36534669 | ||
Update on the evaluation of hypersensitivity reactions to betalactams | Q37365661 | ||
Basophil activation tests in the evaluation of immediate drug hypersensitivity | Q37502644 | ||
International Consensus on drug allergy. | Q38201761 | ||
In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs | Q38228927 | ||
Cellular in vitro diagnosis of adverse drug reactions | Q38539744 | ||
The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. | Q38551689 | ||
In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper | Q39909074 | ||
Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study | Q43034978 | ||
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. | Q43253611 | ||
Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization | Q43982212 | ||
Detection and quantification of drug-specific T cells in penicillin allergy | Q46156607 | ||
Cellular allergen stimulation test with acetylsalicylic acid-lysine is not a useful test to discriminate between asthmatic patients with and without acetylsalicylic acid sensitivity | Q46228661 | ||
Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge | Q46231257 | ||
The usefulness of skin tests to prove drug hypersensitivity | Q46485669 | ||
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper | Q46912843 | ||
In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. | Q53368356 | ||
Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics | Q62130110 | ||
Hypersensitivity reactions to drugs: correlation between clinical probability score and laboratory diagnostic procedures | Q70932712 | ||
The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity | Q73133577 | ||
Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations | Q73794206 | ||
The use of skin testing in the investigation of cutaneous adverse drug reactions | Q77383791 | ||
Predictive capacity of histamine release for the diagnosis of drug allergy | Q77918446 | ||
General considerations for skin test procedures in the diagnosis of drug hypersensitivity | Q78048816 | ||
CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity | Q79839787 | ||
P433 | issue | 1 | |
P407 | language of work or name | German | Q188 |
P304 | page(s) | 19-28 | |
P577 | publication date | 2017-01-01 | |
P1433 | published in | Die Dermatologie | Q15756740 |
P1476 | title | [Diagnostics of drug hypersensitivity reactions]. | |
P478 | volume | 68 |
Search more.